Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Prospective Cohort of Patient With Coronary Stents Undergoing Non Cardiac Surgery (RECO)

This study has been completed.
Information provided by:
University Hospital, Grenoble Identifier:
First received: January 7, 2010
Last updated: January 12, 2010
Last verified: January 2010
Non cardiac surgery in patients with coronary stents is complicated with cardiovascular and hemorrhagic events associated with perioperative management of antiplatelet agents. Several guidelines have outlined the importance of maintaining antiplatelet agents throughout surgical procedures to prevent cardiovascular complications. On the other hand, interruption of antiplatelet agents is still a usual standard to avoid surgical complications. We investigate the impact of perioperative antiplatelet drugs management on these complications, through a multicenter, prospective cohort (RECO stands for "Registre des patients porteurs d'Endoprothèses Coronaires, Opérés de chirurgie non cardiaque"), including all patients with coronary stents undergoing non cardiac surgery or invasive procedures. The aim of this study is primarily to measure the incidence of cardiovascular (including stent thrombosis) and hemorrhagic complications and to identify pre and postoperative risk factors associated with these complications.

Cardiovascular Complications
Hemorrhagic Complications

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Multicenter, Prospective Cohort of Patient With Coronary Stents Undergoing Non Cardiac Surgery or Invasive Procedures.

Further study details as provided by University Hospital, Grenoble:

Primary Outcome Measures:
  • Composite cardiovascular and hemorrhagic postoperative complications [ Time Frame: 30 days ]

Secondary Outcome Measures:
  • Postoperative death [ Time Frame: 30 days ]

Enrollment: 1312
Study Start Date: February 2006
Study Completion Date: January 2010
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with coronary stents undergoing non cardiac surgery or invasive procedures

Inclusion Criteria:

  • 18 years old or more
  • patient requiring a non cardiac surgery
  • patient with a coronary stent
  • patient agree for personal health data collection and analysis

Exclusion Criteria:

  • patient less than 18 years
  • patient unable to understand
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01045850

  Show 53 Study Locations
Sponsors and Collaborators
University Hospital, Grenoble
Principal Investigator: Pierre ALBALADEJO, MD University Hospital, Grenoble
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Professor ALBALADEJO Pierre, University Hospital Grenoble Identifier: NCT01045850     History of Changes
Other Study ID Numbers: DTCIC-09-29
CFAR ( Other Identifier: Collège Français d'Anesthésie Réanimation )
Study First Received: January 7, 2010
Last Updated: January 12, 2010

Keywords provided by University Hospital, Grenoble:
coronary stents
non cardiac surgery
cardiovascular complications
hemorrhagic complications
antiplatelet agents
bare metal stent
drug eluting stent
surgery processed this record on May 25, 2017